KPIs & Operating Metrics(New)
Growth Metrics

Abbott Laboratories (ABT) FCF Payout Ratio (2016 - 2026)

Abbott Laboratories' FCF Payout Ratio history spans 18 years, with the latest figure at 1.2 for Q1 2026.

  • On a quarterly basis, FCF Payout Ratio rose 9.0% to 1.2 in Q1 2026 year-over-year; TTM through Mar 2026 was 0.57, a 3.23% decrease, with the full-year FY2025 number at 0.56, down 7.85% from a year prior.
  • FCF Payout Ratio hit 1.2 in Q1 2026 for Abbott Laboratories, up from 0.39 in the prior quarter.
  • Over the last five years, FCF Payout Ratio for ABT hit a ceiling of 1.53 in Q1 2024 and a floor of 0.36 in Q3 2022.
  • Historically, FCF Payout Ratio has averaged 0.71 across 5 years, with a median of 0.48 in 2022.
  • Biggest five-year swings in FCF Payout Ratio: skyrocketed 213.66% in 2023 and later plummeted 47.34% in 2024.
  • Tracing ABT's FCF Payout Ratio over 5 years: stood at 0.48 in 2022, then fell by 18.9% to 0.39 in 2023, then grew by 14.66% to 0.45 in 2024, then decreased by 12.05% to 0.39 in 2025, then surged by 205.61% to 1.2 in 2026.
  • Business Quant data shows FCF Payout Ratio for ABT at 1.2 in Q1 2026, 0.39 in Q4 2025, and 0.45 in Q3 2025.